维普中文期刊产品整合服务
13篇 您的检索式:作者名="Yazer M"
    题名 作者 年代 出处 被引量
1Significant association between ABO blood group and pancreatic cancer显示文摘AIM:To evaluate whether the ABO blood group is related to pancreatic cancer risk in the general population of the United States.METHODS:Using the University of Pittsburgh's clinicalpancreatic cancer registry,the blood donor database from our local blood bank (Central Blood Bank),and the blood product recipient database from the regional transfusion service (Centralized Transfusion Service) in Pittsburgh,Pennsylvania,we identified 274 pancreatic cancer patients with previously determined serological ABO blood group information.The ABO blood group frequency was compared between these patients and 708842 individual,community-based blood donors who had made donations to Pittsburgh's Central Blood Bank between 1979 and 2009.RESULTS:The frequency of blood group A was statistically significantly higher amongst pancreatic cancer patients compared to its frequency amongst the regional blood donors [47.63% vs 39.10%,odds ratio (OR)=1.43,P=0.004].Conversely,the frequency of blood group O was significantly lower amongst pancreatic cancer patients relative to the community blood donors (32.12% vs 43.99%,OR=0.60,P=0.00007).There were limited blood group B (n=38) and AB (n=17) pancreatic cancer patients;the overall P trend value comparing patient to donor blood groups was 0.001.CONCLUSION:The ABO blood group is associated with pancreatic cancer risk.Future studies should examine the mechanism linking pancreatic cancer risk to ABO blood group.Julia B Greer Mark H Yazer Jay S Raval M Michael Barmada Randall E Brand David C Whitcomb 2010World Journal of Gastroenterology2010,16,44:10
2The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC显示文摘YAZER M H PODLOSKKY L CLARKE G 2004Transfusion2004,44,:1
3Chimerism and mosaicism are important causes of ABO phenotype and genotype discrepan- cies显示文摘Cho D Lee J S Yazer M H 2006Immunohematology2006,22,:1
4Blood salvage and cancer sur- gery : a meta-analysis of available studies 显示文摘Waters JH Yazer M Chen YF 2012Transfusion2012,52,10:1
5Transfusion practice and safety : current status and possibilities for improvement 显示文摘Murphy MF Stanworth SJ Yazer M 2011Vox Sang2011,100,1:1
6Amino-aeid substitution in the disordered loop of blood group B- glycosyltransferase enzyme causes weak B phenotype 显示文摘Yazer MH Denomme GA Rose NL el M 2005Transfusion2005,45,7:1
7Blood salvage and cancer surgery: a meta-analysis of available studies 显示文摘Waters JH Yazer M Chen YF 2012Transfusion (Paris)2012,52,:1
8A comparison of hemolysis and red cell mechanical fragility in blood collected with different cell salvage suction devices显示文摘Yazer M H Waters J H Eikin K R 0,,06:1
9Amino-acid substi- tutionin the disordered loop of blood group B glycosyltrans- ferase enzyme causes weak B phenotype 显示文摘Yazer M H Denomme GA Rose NL 2005Transfusion2005,45,7:1
10A comparison of hemolysis and red cell mechanical fragility in blood collected with different cell salvage suction devices显示文摘YAZER M H WATERS J H ELKIN K R 2008Transfusion2008,48,6:1
11Severe neerotizing pneumonia in a child with pandemic (H1N1) influenza 显示文摘Yazer J Giacomantonio M Macdonald N 2011CMAJ2011,183,2:1
12The effect ofsalvaged blood on coagulation function as measured bythromboelastography显示文摘KONIG G YAZER M H WATERS J H 2013Transfusion2013,53,6:1
13安全合理的输血显示文摘本文要点 遵循循证学指南可以减少输血不良反应,同时也可避免血制品的浪费 对于血流动力学稳定、无症状的心血管疾病患者,当血红蛋白低于80g/L时,需输注红细胞 对于血小板高于50×10^9/L或INR低于2.0的患者,可耐受创伤性操作,无需纠正血象 尽可能寻求其他治疗方案来代替输注血制品,以解决患者的临床问题 获得患者知情同意,充分告知患者输血的风险。Micahel F Murphy Jonathan H Waters Erica M Wood Mark H Yazer 王倩(译) 许小平(校) 2013英国医学杂志中文版2013,16,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费